| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/22/2003 | EP1276852A2 Viruses comprising mutated ion channel protein |
| 01/22/2003 | EP1276851A2 Tolerance-inducing thymus-bone marrow composite tissue construct and organ |
| 01/22/2003 | EP1276850A2 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 01/22/2003 | EP1276849A2 Albumin fusion proteins |
| 01/22/2003 | EP1276764A1 Human polynucleotides, polypeptides, and antibodies |
| 01/22/2003 | EP1276762A1 Porphyromonas gingivalis recombinant proteins and truncations |
| 01/22/2003 | EP1276761A2 New bromodomain protein |
| 01/22/2003 | EP1276755A1 Novel compounds |
| 01/22/2003 | EP1276497A2 Mixture of defibrotide and g-csf and its use for activating haematopoietic progenitors |
| 01/22/2003 | EP1276486A2 Joint repair using mesenchymal stem cells |
| 01/22/2003 | EP1276431A1 Method for expansion of epithelial stem cells |
| 01/22/2003 | EP1276367A1 Novel 'oxy' cms brassica napus plant corrected for chlorosis using hexaploid bridging material generated through protoplast fusion |
| 01/22/2003 | EP1179183A4 A method for identifying pre-neoplastic and/or neoplastic states in mammals |
| 01/22/2003 | EP1161142A4 Methods for culturing fluid-filled sensory organs |
| 01/22/2003 | EP1009855A4 Method for separating cells |
| 01/22/2003 | EP0973901B1 Flip gene and flip protein |
| 01/22/2003 | EP0832199A4 Fucosyltransferase genes and uses thereof |
| 01/22/2003 | CN1392797A High mannose proteins and method of making mannose proteins |
| 01/22/2003 | CN1392253A Method of utilizing three-dimensional rack seed cell double phase inoculation to construct engineered tissue |
| 01/22/2003 | CN1392252A Cultivating method for increasing sweet wormwood organ biomass and artemisine content |
| 01/22/2003 | CN1392251A Method of promoting haematococcus pluvialis growing multiplication and regulating astaxanthin synthesis and accumulation in photobiological reactor |
| 01/22/2003 | CN1392250A Method of regulating haematococcus pulvialis population density and synthesing and accumulating astaxanthin in photoreactor |
| 01/22/2003 | CN1392242A Circulation and physiological stress simulating engineering tissue three-dimensional cultivation device |
| 01/22/2003 | CN1099423C Human neuropeptide receptor |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509449 To provide a detection method for assaying the polypeptide using the monoclonal antibody |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509190 DNA regulatory element for the expression of transgenes in neurons of the mouse forebrain |
| 01/21/2003 | US6509155 Characterization, diagnosis, prevention, and treatment of cell signaling, immune, and cell proliferative disorders, particularly colon cancer |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | US6509016 Delaying recurrence of ganglioside 2 associated tumors; antibody comprising the light and heavy chain variable region sequences contained in seq id no: 2 and 4 |
| 01/21/2003 | US6509015 Human antibodies that bind human TNFa |
| 01/21/2003 | US6508714 Split spool type flexible coupling |
| 01/21/2003 | CA2234071C Intensive homologous promoter obtained from hamsters |
| 01/21/2003 | CA2204253C Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 01/21/2003 | CA2098720C Cellular composition for the treatment of human or animal organisms |
| 01/18/2003 | CA2352702A1 Novel human proton gated ion channel |
| 01/17/2003 | CA2407295A1 Transgenic non-human mammal |
| 01/16/2003 | WO2003005301A1 In vitro method of evaluating the biological activity of compounds on a large scale in suitable physiological or pathological conditions |
| 01/16/2003 | WO2003004995A2 High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation |
| 01/16/2003 | WO2003004992A2 Mammalian sweet and amino acid heterodimeric taste receptors |
| 01/16/2003 | WO2003004694A1 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 01/16/2003 | WO2003004684A2 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES |
| 01/16/2003 | WO2003004683A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | WO2003004661A2 Adenovital vectors with cell type specificity for mesenchymal cells |
| 01/16/2003 | WO2003004659A2 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 01/16/2003 | WO2003004658A2 Gene expression in plastids based on replicating vectors |
| 01/16/2003 | WO2003004657A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004655A2 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 01/16/2003 | WO2003004651A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | WO2003004650A2 Group b streptococcus antigens and corresponding dna fragments |
| 01/16/2003 | WO2003004627A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | WO2003004626A1 A bioprocess for the generation of cells derived from spheroid-forming cells |
| 01/16/2003 | WO2003004625A1 Methods of generating human cd4+ th2 cells and uses thereof |
| 01/16/2003 | WO2003004624A1 Culture media for plants and plant cells, tissues and organs containing an organic nitrogen source and a phosphorous ester source |
| 01/16/2003 | WO2003004620A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004616A2 Dendritic cell isolation methods |
| 01/16/2003 | WO2003004615A2 Secreted proteins |
| 01/16/2003 | WO2003004613A2 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | WO2003004611A2 Human olfactory nucleotide-gated ion channels |
| 01/16/2003 | WO2003004607A2 Aggrecanase molecules |
| 01/16/2003 | WO2003004605A2 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 01/16/2003 | WO2003004604A2 Phage displayed pdz domain ligands |
| 01/16/2003 | WO2003004600A2 Improvement of viral uptake into cells and tissues |
| 01/16/2003 | WO2003004066A1 Gene therapeutics |
| 01/16/2003 | WO2003004037A1 Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours |
| 01/16/2003 | WO2003003906A2 Diagnostic and screening methods for bladder cancer |
| 01/16/2003 | WO2002088178A3 Antigens of group b streptococcus and corresponding dna fragments |
| 01/16/2003 | WO2002077023A3 A new essential downstream component of the wingless signalling pathway |
| 01/16/2003 | WO2002051985A3 Culturing tissue using magnetically generated mechanical stresses |
| 01/16/2003 | WO2002046387A3 Plant derived hydroxy phenyl pyruvate dioxygenases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases |
| 01/16/2003 | WO2002044343A3 Tolerizing allografts of pluripotent stem cells |
| 01/16/2003 | WO2002043661A3 Recombinant anti-cd30 antibodies and uses thereof |
| 01/16/2003 | WO2002042445A3 Differentiated cells suitable for human therapy |
| 01/16/2003 | WO2002041930A8 Connective tissue substitutes, method of preparation and uses thereof |
| 01/16/2003 | WO2002040540A3 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 01/16/2003 | WO2002031144A3 Identification of cytotoxic activity from the ink of aplysia punctata |
| 01/16/2003 | WO2002022806A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 01/16/2003 | WO2002022080A8 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 01/16/2003 | WO2002020813A3 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 01/16/2003 | WO2002018609A3 Methods for stable transduction of cells with viral vectors |
| 01/16/2003 | WO2002018546A3 Plasma-derived-fibrin-based matrices and tissue |
| 01/16/2003 | WO2002016595A3 Kidney-specific protein |
| 01/16/2003 | WO2002016587A3 Microtubule-associated proteins and tubulins |
| 01/16/2003 | WO2002014352A3 Therapeutic compounds for ovarian cancer |
| 01/16/2003 | WO2002010406A3 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 01/16/2003 | WO2002002783A3 Expression vectors |
| 01/16/2003 | WO2002002772A3 Human extracellular matrix (ecm)-related tumor marker |
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | WO2001092549A3 Method and composition for targeting an adenoviral vector |
| 01/16/2003 | WO2001092490A3 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/16/2003 | WO2001087937A3 G-protein coupled receptors |
| 01/16/2003 | WO2001079538A3 Cell-binding nucleic acid molecules (aptamers) |
| 01/16/2003 | WO2001070174A8 Vegf-modulated genes and methods employing them |
| 01/16/2003 | WO2001068880A9 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/16/2003 | WO2001068805A9 Human olfactory receptors and genes encoding same |
| 01/16/2003 | WO2001059093A9 Full-length infectious cdna clones of tick borne flavivirus |
| 01/16/2003 | WO2001058954A9 Trade molecules and uses related thereto |
| 01/16/2003 | US20030014777 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |